Media Lab Valuation
Is MLLAB undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of MLLAB when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: MLLAB (€2.2) is trading above our estimate of fair value (€0.03)
Significantly Below Fair Value: MLLAB is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for MLLAB?
Key metric: As MLLAB is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is MLLAB's PE Ratio? | |
|---|---|
| PE Ratio | 57.4x |
| Earnings | €90.90k |
| Market Cap | €5.21m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 3.5x |
| Enterprise Value/EBITDA | 21x |
| PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does MLLAB's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 45.3x | ||
CGM Cegedim | 75.8x | 49.8% | €152.9m |
EQS Equasens Société anonyme | 14.9x | 11.4% | €628.3m |
ALTER Theradiag | 39x | n/a | €16.4m |
ECL.N0000 eChannelling | 51.6x | n/a | LK₨1.8b |
MLLAB Media Lab | 57.4x | n/a | €5.2m |
Price-To-Earnings vs Peers: MLLAB is expensive based on its Price-To-Earnings Ratio (57.4x) compared to the peer average (45.3x).
Price to Earnings Ratio vs Industry
How does MLLAB's PE Ratio compare vs other companies in the European Healthcare Services Industry?
| 2 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 2 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: MLLAB is expensive based on its Price-To-Earnings Ratio (57.4x) compared to the European Healthcare Services industry average (18.2x).
Price to Earnings Ratio vs Fair Ratio
What is MLLAB's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 57.4x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate MLLAB's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Equasens Société anonyme
€628.3m
Provides healthcare IT solutions in Europe.
EQS
€41.80
7D
-8.2%
1Y
-28.3%
Laboratoires Euromedis Société anonyme
€13.3m
Through its subsidiaries, designs, manufactures, and distributes medical equipment under the Euromedis brand name for healthcare professionals, local communities, and individuals in France and internationally.
ALEMG
€4.66
7D
-10.4%
1Y
-3.7%
emeis Société anonyme
€983.6m
Operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals.
EMEIS
€6.11
7D
-5.3%
1Y
-98.5%